San Francisco, CA
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
ltztherapeutics.comThese are collections LTZ Therapeutics is a part of. Click on the collection name to view similar companies.
Series A
$40,000,000
Series A
$20,000,000
Seed
$10,000,000
Seed
$17,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on LTZ Therapeutics.